Saliva Testing in Dentistry. What Changes Care and What Still Needs Proof
A patient arrives with a saliva report, a list of bacteria, and recommendations for products promising a healthier mouth. The dentist faces a practical decision before discussing treatment. Does this information reveal something the examination missed, change an appropriate recommendation, or simply put numbers beside a problem already understood.
That distinction sits at the center of salivary diagnostics. Saliva contains microbial material, proteins, and other measurable signals, and collection is usually painless. Its potential is substantial. Yet accurately detecting a bacterium is different from diagnosing disease, and diagnosing disease is different from demonstrating that a new testing strategy improves outcomes. For practicing dentists, the useful endpoint is a better decision, followed by better care.
The biology explains why interpretation matters. Caries and periodontitis emerge from interactions among microbial communities, diet, saliva, host defenses, and behavior. There is no accepted list of twelve bacteria responsible for everything dentists treat. Finding Porphyromonas gingivalis does not establish active periodontal destruction, and saliva collected from the whole mouth cannot pinpoint every affected pocket. Probing, attachment measurements, radiographs, and medical history remain essential. A falling bacterial count or inflammatory marker is encouraging only when interpreted alongside clinical findings.
Some of the most practical saliva assessment begins with function. Xerostomia is the sensation of dryness, while hyposalivation is objectively reduced flow. They overlap without being interchangeable. Measuring flow can document a problem that changes preventive intensity or prompts medical investigation. A single saliva pH reading is less decisive. It cannot diagnose reflux or reconstruct overnight acid exposure, and the familiar enamel threshold of pH 5.5 varies with surrounding mineral concentrations. Rapid enamel loss warrants investigating dietary acids, reflux, vomiting, medications, and mechanical wear. Sugar free drinks can still erode teeth.
New technology is expanding what practices can measure. Wenyuan Shi, PhD, at ADA Forsyth has helped advance rapid bacterial detection and targeted antimicrobial research. Tina Saw, DDS, has built Oral Genome around a chairside saliva panel, smartphone interpretation, and digital reporting. Its appeal is convenience and patient engagement, but the company positions the product as a wellness tool rather than a disease diagnostic. Harmony Health has organized pilots combining testing with education and care coordination for underserved patients. These efforts demonstrate research and implementation progress. Their clinical value depends on what the information adds to care.
Other products require the same scrutiny. Bristle offers microbiome sequencing, while Dentulu provides access to several third party testing services. They should not be treated as interchangeable assays. Dentists need evidence for the specific measurement, score, patient population, and proposed action. CLIA certification supports laboratory quality, but does not establish that a proprietary risk score predicts disease or that recommended supplements prevent it. Partner logos, awards, and testimonials answer different questions from independent clinical validation.
Insurance participation has made testing more tangible. PDS Health has partnered with Delta Dental of Massachusetts and United Concordia on funded periodontal screening programs. PDS reported that more than half of screened Massachusetts members accepted recommended periodontal treatment, with improved screening scores among returning patients. That is an encouraging engagement signal. Without a comparable group receiving the same care and education without screening, however, the report cannot show how much benefit came from the test itself. Treatment acceptance matters when the treatment is appropriate, and an improved score does not establish fewer lost teeth.
For the practice, coverage requires its own verification. A funded pilot is not a universal insurance benefit, and a CDT code does not guarantee payment. Teams should confirm eligibility, exclusions, and patient costs before collection. They should also know who explains results, how those results enter the chart, and what happens when the report conflicts with the examination. A test sold as reassurance can create confusion if nobody owns the follow through.
Patient communication is where the technology may earn its place. A visible measurement can make an invisible process easier to understand and encourage prevention. The explanation should remain proportionate to the evidence. Periodontal treatment can modestly improve glycemic control in patients with diabetes. Evidence does not justify promising that saliva screening or periodontal therapy prevents heart attacks or Alzheimer’s disease. The ADA’s September 2026 guidance places salivary oral cancer adjuncts in research settings. Suspicious lesions still require appropriate assessment and biopsy or referral, regardless of a reassuring test.
Treatment should follow that same discipline. A bacterial report is not an automatic indication for antibiotics. The EFP recommends against routine systemic antibiotics alongside periodontal instrumentation. Antimicrobial mouthrinses also need a defined purpose, while fluoride rinses serve a different preventive role. Experimental therapies targeting selected organisms offer an intriguing future, but early proof of concept does not establish durable cavity prevention.
Medical and dental record integration may provide another useful bridge. Under Stephen Thorne’s leadership, PDS deployed Epic across its supported practices, and ADA Forsyth later selected PDS Health Technologies for its clinic implementation. Access to medications, laboratory results, and diagnoses can support informed treatment planning. Its value still depends on clinicians using the information and completing coordination, rather than merely connecting records.
Before introducing any saliva test, define what a positive and negative result would change, what evidence supports those actions, and how benefit will be measured. Dentistry already practices prevention. The opportunity is to strengthen it with information that earns its cost and its place in the appointment.
What would a saliva result change in your next treatment plan?
Join the Conversation!